Newsroom

CHA HEALTH SYSTEMS PARTNERS WITH CERAS HEALTH TO IMPROVE REAL-TIME CARE COORDINATION AND HEALTH OUTCOMES FOR PATIENTS

LOS ANGELES—July 6, 2022—CHA Health Systems (CHS), a global leader in healthcare and biotechnology, today announced a partnership with digital healthcare services company Ceras Health (Ceras) to use its breakthrough digital transitions of care solutions, to drive improved health outcomes and care coordination for the health system’s Medicare and other vulnerable patient populations.

(L to R) Marcel Loh, President and Chief Executive Officer, CHA Hollywood Presbyterian Medical Center; Yongseok Kim, Chief Executive Officer, CHA Health Systems; Udaya Devineni, President and Chief Executive Officer, Ceras Health; and Anita Waxman, Co-Founder, Business Development, Ceras Health at the signing ceremony of Memorandum of Understanding (MOU) on partnership between the two companies for digital transitions of care solutions.

CHS has a global network consisting of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. In the US, CHS operates CHA Hollywood Presbyterian Medical Center (CHA HPMC), a nationally recognized acute care facility in the Los Angeles area, which offers comprehensive health care services with 469 beds, including 89 skilled nursing beds. The hospital has a medical staff of more than 500 physicians and specialists, representing 69 specialties and 75 different countries.

The partnership will enable CHS’s network of physicians to improve patient health outcomes, prevent readmissions, and enhance patient experience by utilizing Ceras’ HIPAA-compliant care monitoring and coordination tools which provide access to patient’s health data in real-time.

“The partnership seamlessly aligns with our commitment to providing comprehensive, patient-centered care; enabling our hospital and physicians to establish an exemplary care model which will transform the healthcare business and patient care journey,” said Yongseok Kim, Chief Executive Officer (CEO) of CHS. “Ceras’ tools and technology will help our physicians understand where patients are in the care continuum and ensure that patients receive the right care to prevent the development of severe conditions; thereby driving the best possible health outcomes in the long term.” CHS and Ceras will also launch a study to look at ways to improve health outcomes for the Medicare population in the area.

Over 42 million Medicare patients across the US visit their doctor less than the recommended frequency, often due to costs and other barriers. As a result, 2 in 3 older adults wait until their condition deteriorates and then use the Emergency Room (ER) as their primary form of care. Once discharged from the hospital, many older patients are unable to understand or take the appropriate steps to monitor and improve their conditions, leading to a high number of readmissions, which adds an additional financial burden to the $750 billion already spent by Medicare.

“Innovation-driven health systems across the country, such as CHS, recognize that the care delivery status quo needs to change, especially for Medicare and other vulnerable populations. Ceras Health’s digital transitions of care solutions have proven to improve outcomes for chronic disease while resulting in high patient satisfaction,” said Udaya Devineni, CEO of Ceras Health. “We look forward to partnering with CHS as they continue to drive innovation to ensure their patients receive high-quality care, with the clinical expertise and care they expect, in the comfort of their own homes. This will improve their outcomes and experience while reducing costs for already burdened healthcare services.”

Ceras’ digital solutions are transforming how healthcare is delivered, especially for Medicare and other vulnerable populations. This will be achieved by using a combination of 24/7 clinical expertise, remote patient monitoring (RPM), advanced analytics and artificial intelligence (AI), and Ceras’ industry-first behavioral change and gamification platform which will help patients get the personalized care they need. The company also provides RPM devices—that monitor vital signs and other health factors—to patients at no cost, which allows physicians to monitor their patient’s recovery and well-being outside the conventional hospital setting.

About CHA Health Systems
CHA Health Systems, headquartered in Seoul, Korea, is a global leader in the biotechnology industry, consisting of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. A leader in biomedical research, CHS is at the forefront of research on cell, gene, and epigenetic development through resource acquisition for future medical use in the treatment of incurable diseases, while fostering the next generation of medical professionals. The group has developed an international reputation for its world-class health treatments and advances in reproductive medicine.

About Ceras Health
Ceras Health is a pioneering digital-first, integrated care provider, utilizing 24/7 clinical expertise and remote monitoring, advanced AI and analytics, connected health devices, and a personalized behavioral change and gamification platform to help and empower patients through their transitions of care. Ceras partners with health systems, providers, and payers, to deliver solutions to vulnerable populations to improve their health outcomes and care experience through digital care with a human touch. To learn more about Ceras Health, visit www.cerashealth.com or email marketing@cerashealth.com .

Media Contact
Hyobin Song
Vice President of Marketing and Communications
CHA Health Systems
hsong@chahealthsystems.com